Trazodone is not an opioid. It is an antidepressant, specifically a type called a serotonin antagonist and reuptake inhibitor (SARI). It works on serotonin, not on the opioid receptors that drugs like morphine, oxycodone, and fentanyl target. Trazodone is also not a controlled substance under federal law, meaning it carries no DEA scheduling.
How Trazodone Actually Works
Trazodone’s effects come from the serotonin system in your brain, which is completely separate from the opioid system. At lower doses, it blocks certain serotonin receptors (along with histamine and adrenaline receptors), which is why it makes people drowsy. At higher doses, it also prevents serotonin from being reabsorbed after it’s released, which is the mechanism that helps with depression. This dose-dependent behavior is why the same drug gets prescribed at a low dose for sleep and a higher dose for mood.
Opioids, by contrast, bind to mu-opioid receptors in the brain and spinal cord. That binding produces pain relief, euphoria, and the respiratory depression that makes opioid overdoses deadly. Trazodone does not bind to these receptors. The two drugs work through entirely different chemical pathways.
Why People Confuse the Two
The confusion likely comes from a few places. Trazodone causes drowsiness and sedation, which can feel superficially similar to the effects of an opioid. It’s also sometimes prescribed alongside pain medications in multimodal pain regimens, which may lead people to assume it’s in the same drug family.
There is one interesting wrinkle in the research that may fuel confusion. Animal studies have found that trazodone’s pain-relieving effects can be partially blocked by naloxone, the drug used to reverse opioid overdoses. This suggests trazodone may indirectly influence the opioid system through its serotonin activity. But “indirectly influencing” a system is very different from being an opioid. Many non-opioid substances, including exercise, affect the body’s natural opioid pathways without being opioids themselves.
What Trazodone Is Prescribed For
The FDA approved trazodone in 1982 for major depressive disorder in adults. That remains its only official indication. In practice, though, it is widely prescribed off-label for insomnia, often at doses lower than those used for depression. Its sedating properties at low doses make it a common choice for people who have trouble sleeping, particularly when other sleep medications carry higher risks of dependence.
Trazodone also shows up in some chronic pain treatment plans, though it is not FDA-approved for pain. Research suggests it is most effective for neuropathic pain, the burning or shooting type caused by nerve damage. One clinical study comparing trazodone to amitriptyline (a tricyclic antidepressant commonly used for pain) in 45 patients with cancer-related nerve pain found equivalent pain relief, with trazodone producing fewer side effects.
Overdose Looks Different From Opioid Overdose
Because trazodone is not an opioid, its overdose profile is distinct. Opioid overdoses are characterized by dangerously slowed breathing, pinpoint pupils, and loss of consciousness, and they respond to naloxone. Trazodone overdose typically involves excessive drowsiness, low blood pressure, fainting, and irregular heartbeat. In one documented case, a person who ingested 2.2 grams of trazodone (far above therapeutic doses) became unconscious, developed breathing difficulty, dangerously low blood pressure, and an irregular heart rhythm. While serious, these symptoms reflect cardiovascular stress rather than the respiratory shutdown seen with opioids.
Naloxone will not reverse a trazodone overdose, because the drug is not acting on opioid receptors.
Dependence and Withdrawal
Trazodone does not produce the physical dependence pattern that opioids do. You won’t develop tolerance requiring escalating doses, and it doesn’t trigger the intense cravings associated with opioid withdrawal. However, stopping trazodone abruptly after prolonged use can cause antidepressant discontinuation syndrome. Symptoms are generally mild and include irritability, anxiety, sleep disruption, and general unease as your brain readjusts its serotonin balance.
If you’ve been taking trazodone for weeks or months, tapering the dose gradually rather than stopping cold turkey reduces the likelihood and severity of these symptoms. People who use trazodone primarily for sleep sometimes develop anxiety about their ability to fall asleep without it, which is a psychological pattern rather than a sign of chemical addiction.
Not a Controlled Substance
Unlike opioids, benzodiazepines, and many other sedating medications, trazodone is not listed on any DEA schedule. It does not require the special prescribing restrictions that controlled substances do. Your pharmacy can transfer and refill trazodone prescriptions under normal rules, and it does not carry the legal risks associated with possessing scheduled drugs. This regulatory status reflects the medical consensus that trazodone has a low potential for abuse compared to opioids or other sedatives.